南非COVID-19疫苗接种计划的成本效益分析
Ijeoma Edoka1, Sheetal Silal2, Lise Jamieson3
1Health Economics and Epidemiology Research Office (HE(2)RO), Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Vaccine
|June 1, 2024
概括
南非的COVID-19疫苗接种计划证明具有成本效益,以低于该国门的成本避免了残疾调整寿命年 (DALYs). 该计划在其前两年提供了良好的价值对金钱.
科学领域:
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
- 流行病学 流行病学
背景情况:
- 南非的COVID-19疫苗接种在2021年2月开始.
- 这项研究追溯评估了疫苗接种计划在最初两年的成本效益.
研究的目的:
- 评估南非COVID-19疫苗接种计划的经济价值.
- 为了比较接种疫苗的成本和健康结果与没有接种疫苗的情况.
主要方法:
- 使用公共付款人视角模型,分析2021年美元的成本.
- 测量健康结果是根据残疾调整的生命年 (DALYs) 避免.
- 考虑了两个时间视野:九个月和二十四个月,并进行了敏感性分析.
主要成果:
- 增量成本效益比 (ICER) 是1600美元/DALY避免 (9个月) 和1300美元/DALY避免 (24个月).
- 包括85%的过度死亡减少了ICER分别为1070美元和660美元.
- 概率灵敏度分析显示,几乎所有模拟都低于南非2300美元/DALY的成本效益值.
结论:
- 南非的COVID-19疫苗接种计划在前两年表现出良好的价值.
- 疫苗每剂量成本显著影响了ICERs.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
01:51Vaccinations
44.4K
Overview
44.4K